These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 23563516)
1. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons. Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T; Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study. Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y; Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473 [TBL] [Abstract][Full Text] [Related]
3. Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: a case-control study. Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; María Mayoral J; Martín V; María Quintana J; González-Candelas F; Galán JC; Tamames S; Acosta AC; Baricot M; Garín O; José García J; Moraga F; Pumarola T; Pediatr Infect Dis J; 2013 Apr; 32(4):330-4. PubMed ID: 23337901 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization. Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Martín V; Saez M; Soldevila N; Quintana JM; Mayoral JM; Astray J; González-Candelas F; Cantón R; Tamames S; Castro A; Baricot M; Alonso J; Pumarola T; Vaccine; 2012 Aug; 30(38):5644-50. PubMed ID: 22796136 [TBL] [Abstract][Full Text] [Related]
5. Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization. Song JY; Lee JS; Wie SH; Kim HY; Lee J; Seo YB; Jeong HW; Kim SW; Lee SH; Park KH; Noh JY; Choi WS; Cheong HJ; Kim WJ Clin Vaccine Immunol; 2015 Feb; 22(2):229-34. PubMed ID: 25540271 [TBL] [Abstract][Full Text] [Related]
6. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation. Demirdogen Cetinoglu E; Uzaslan E; Sayıner A; Cilli A; Kılınc O; Sakar Coskun A; Hazar A; Kokturk N; Filiz A; Polatli M; Hum Vaccin Immunother; 2017 Sep; 13(9):2072-2077. PubMed ID: 28708954 [TBL] [Abstract][Full Text] [Related]
7. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study. Suzuki K; Kondo K; Washio M; Nakashima K; Kan S; Imai S; Yoshimura K; Ota C; Ohfuji S; Fukushima W; Hirota Y Hum Vaccin Immunother; 2019; 15(9):2171-2177. PubMed ID: 30785356 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain. Domínguez À; Soldevila N; Toledo D; Torner N; Force L; Pérez MJ; Martín V; Rodríguez-Rojas L; Astray J; Egurrola M; Sanz F; Castilla J; PLoS One; 2017; 12(2):e0171943. PubMed ID: 28187206 [TBL] [Abstract][Full Text] [Related]
9. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience. Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277 [TBL] [Abstract][Full Text] [Related]
10. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. Simonsen L; Taylor RJ; Young-Xu Y; Haber M; May L; Klugman KP mBio; 2011 Jan; 2(1):e00309-10. PubMed ID: 21264063 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching. Song JY; Noh JY; Lee JS; Wie SH; Kim YK; Lee J; Jeong HW; Kim SW; Lee SH; Park KH; Choi WS; Cheong HJ; Kim WJ PLoS One; 2018; 13(12):e0207918. PubMed ID: 30521553 [TBL] [Abstract][Full Text] [Related]
12. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis. Zhang YY; Tang XF; Du CH; Wang BB; Bi ZW; Dong BR Hum Vaccin Immunother; 2016 Dec; 12(12):3056-3064. PubMed ID: 27629584 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Yin M; Huang L; Zhang Y; Yu N; Xu X; Liang Y; Ni J Expert Rev Vaccines; 2018 Jul; 17(7):653-663. PubMed ID: 29961353 [TBL] [Abstract][Full Text] [Related]
14. Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain. Domínguez À; Soldevila N; Toledo D; Godoy P; Castilla J; Force L; Morales M; Mayoral JM; Egurrola M; Tamames S; Martín V; Astray J; PLoS One; 2016; 11(1):e0147931. PubMed ID: 26824383 [TBL] [Abstract][Full Text] [Related]
15. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Castilla J; Godoy P; Domínguez A; Martínez-Baz I; Astray J; Martín V; Delgado-Rodríguez M; Baricot M; Soldevila N; Mayoral JM; Quintana JM; Galán JC; Castro A; González-Candelas F; Garín O; Saez M; Tamames S; Pumarola T; Clin Infect Dis; 2013 Jul; 57(2):167-75. PubMed ID: 23532475 [TBL] [Abstract][Full Text] [Related]
16. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study]. Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749 [No Abstract] [Full Text] [Related]
17. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study. Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A; Hum Vaccin Immunother; 2012 May; 8(5):639-44. PubMed ID: 22634442 [TBL] [Abstract][Full Text] [Related]
18. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Christenson B; Hedlund J; Lundbergh P; Ortqvist A Eur Respir J; 2004 Mar; 23(3):363-8. PubMed ID: 15065822 [TBL] [Abstract][Full Text] [Related]
19. Influenza Vaccine Effectiveness in Preventing Severe Outcomes in Patients Hospitalized with Laboratory-Confirmed Influenza during the 2017-2018 Season. A Retrospective Cohort Study in Catalonia (Spain). Acosta L; Soldevila N; Torner N; Martínez A; Ayneto X; Rius C; Jané M; Domínguez A; The Influenza Surveillance Network Of Catalonia Pidirac Viruses; 2021 Jul; 13(8):. PubMed ID: 34452337 [TBL] [Abstract][Full Text] [Related]
20. Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study. Kim JH; Chun BC; Song JY; Kim HY; Bae IG; Kim DM; Choi YH; Jun YH; Choi WS; Kang SH; Kwon HH; Jeong HW; Kee SY; Hur J; Chung JW; Yoon YK; Sohn JW; Yang KS; Kim MJ Vaccine; 2019 May; 37(21):2797-2804. PubMed ID: 31005428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]